Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis.
Atherosclerosis is a progressive disease in which endothelial cell dysfunction, macrophage foam cell formation, and smooth muscle cell migration and proliferation, lead to the loss of vascular homeostasis. Oxidized low-density lipoprotein (oxLDL) may play a pre-eminent function in atherosclerotic lesion formation, even if their role is still debated. Several types of scavenger receptors (SRs) such as SR-AI/II, SRBI, CD36, lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), toll-like receptors (TLRs) and others can promote the internalization of oxLDL. They are expressed on the surface of vascular wall cells (endothelial cells, macrophages and smooth muscle cells) and they mediate the cellular effects of oxLDL. The key influence of both oxLDL and SRs on the atherogenic process has been established in atherosclerosis-prone animals, in which antioxidant treatment and/or silencing of SRs has been shown to reduce atherogenesis. Despite some discrepancies, the indication from cohort studies that there is an association between oxLDL and cardiovascular (CV) events seems to point toward a role for oxLDL in atherosclerotic plaque progress and disruption. Finally, randomized clinical trials using antioxidants have demonstrated benefits only in high-risk patients, suggesting that additional proofs are still needed to better define the involvement of each type of modified LDL in the development of atherosclerosis.
['Di Pietro|Natalia|N|', 'Formoso|Gloria|G|', 'Pandolfi|Assunta|A|']
D000818:Animals D050197:Atherosclerosis D018450:Disease Progression D042783:Endothelial Cells D005487:Foam Cells D006801:Humans D008077:Lipoproteins, LDL D008264:Macrophages D032389:Myocytes, Smooth Muscle D058226:Plaque, Atherosclerotic D016032:Randomized Controlled Trials as Topic
Atherosclerosis Macrophages Oxidized low-density lipoproteins